| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2009 | US20090186810 Potassium channel modulators and platelet procoagulant activity |
| 07/23/2009 | US20090186809 Use of valproic acid for the topical treatment of mild to moderate acne vulgaris |
| 07/23/2009 | US20090186805 Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance |
| 07/23/2009 | US20090186378 recombinant vectors encoding the FK-520 polyketide synthase and FK-520 modification enzymes can be used to produce the FK-520 polyketide; for immunosuppression or to stimulate nerve growth and regeneration |
| 07/23/2009 | US20090186376 sVEGFR-2 AND ITS ROLE IN LYMPHANGIOGENESIS MODULATION |
| 07/23/2009 | US20090186338 Oligonucleotides originating from sequences coding for the surface component of ptlv envelope proteins and their uses |
| 07/23/2009 | US20090186109 Parthenolide free bioactive ingredients from feverfew (tanacetum parthenium) and processes for their production |
| 07/23/2009 | US20090186107 Orally Administrable Films and Preparation Thereof |
| 07/23/2009 | US20090186105 Device and Composition for the Delivery of a Preservative-Free Balsamic Cream |
| 07/23/2009 | US20090186103 Process for obtaining dried plant material |
| 07/23/2009 | US20090186099 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 07/23/2009 | US20090186088 Inhalable drug |
| 07/23/2009 | US20090186086 Solid multilayer oral dosage forms |
| 07/23/2009 | US20090186084 Form of administration of racecadotril |
| 07/23/2009 | US20090186083 Method for stabilization of isoxazole compound |
| 07/23/2009 | US20090186082 Method of manufacturing modified release dosage forms |
| 07/23/2009 | US20090186078 Treatment of triple receptor negative breast cancer |
| 07/23/2009 | US20090186076 Combined Use of TGF-Beta Signaling Inhibitor and Antitumor Agent |
| 07/23/2009 | US20090186066 Method for production of chitosan-based films with enhanced cell adhering capacity, resulting product and applications |
| 07/23/2009 | US20090186064 Antimicrobial material and method for making the same |
| 07/23/2009 | US20090186059 Devices and methods for elution of nucleic acid delivery complexes |
| 07/23/2009 | US20090186056 Compositions and methods for preventing infection |
| 07/23/2009 | US20090186039 Novel use of grp 94 in virus infection |
| 07/23/2009 | US20090186038 Methods of Preventing or Treating Respiratory Conditions |
| 07/23/2009 | US20090186035 Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 07/23/2009 | US20090186034 Gene expression markers for inflammatory bowel disease |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186024 Gene Expression Signatures for Oncogenic Pathway Deregulation |
| 07/23/2009 | US20090186016 Augmentation of endothelial thromboresistance |
| 07/23/2009 | US20090186014 Method for treatment of pancreatitis |
| 07/23/2009 | US20090186009 Solid matter containing coenzyme q |
| 07/23/2009 | US20090185999 Derivatives of gefitinib |
| 07/23/2009 | US20090185996 Hydroxyethyl starch-containing polypeptide compositions |
| 07/23/2009 | US20090185995 Lubricious, non-tacky personal lubricant |
| 07/23/2009 | US20090185990 Bioactive compositions from theacea plants and processes for their production and use |
| 07/23/2009 | US20090185983 Aqueous medicament preparations for the production of propellant gas-free aerosols |
| 07/23/2009 | US20090185975 Diagnostic probe for conformation disease |
| 07/23/2009 | US20090185973 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 07/23/2009 | DE4418115B4 Galenische Formulierungen Pharmaceutical formulations |
| 07/23/2009 | DE202008003335U1 Pharmazeutische Zusammensetzung zur Behandlung und Prophylaxe der Migräne A pharmaceutical composition for the treatment and prophylaxis of migraine |
| 07/23/2009 | DE19521753B4 Monomere Insulinanalogonformulierungen Monomeric insulin analog formulations |
| 07/23/2009 | DE102008005505A1 Use of a pharmaceutical formulation comprising trimagnesium dicitrate salt or trimagnesium dicitrate, to treat pathological calcifications including arteriosclerosis, where the compounds are present in hydrate or anhydrate form |
| 07/23/2009 | DE102008005498A1 Adherent, sperm blocking drug combination with contraceptive effect, useful as contraceptive, comprises deionized water, polysaccharide-gum, and alcohol as lubricant, where composition has specific total viscosity |
| 07/23/2009 | DE102008005493A1 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate 4- (pyrrolo [2,3-c] pyridine-3-yl) -pyrimidin-2-yl-amine derivatives |
| 07/23/2009 | DE102008005484A1 Induktion und Förderung der Arteriogenese Induction and promotion of arteriogenesis |
| 07/23/2009 | DE102008005172A1 Composition, useful for producing an agent for intraoperative application in abdominal cavity to prevent postoperative adhesion, comprises two components of polysaccharide, hyaluronic acid and/or phospholipid, and an antiinflammatory agent |
| 07/23/2009 | DE102008004920A1 Blood soluble, flow resistance reducing composition, useful e.g. to increase arterial blood flow, capillary blood flow and peripheral vascular resistance, comprises hydroxyethyl amylose and further hydroxyethyl starch in a carrier solution |
| 07/23/2009 | DE102008004694A1 Benzodiazepin und/oder Benzodiazepinderivate enthaltende pharmazeutische Zusammensetzung Benzodiazepine and / or benzodiazepine derivatives containing pharmaceutical composition |
| 07/23/2009 | DE102008004386A1 Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen Use of a Acetylsalicylsäuresalzes for treating viral infections |
| 07/23/2009 | DE102007056488A1 Composition, useful e.g. transfection comprises a non-viral gene delivery system containing e.g. cationic lipid, and an agent for partial suppression and/or activation of innate intracellular and/or intercellular immune defense |
| 07/23/2009 | DE102007054497B3 New crystalline hydrate form of dodecanedioic acid 4-((2S,3R)-3-((S)-3-(4-fluoro-phenyl)-3-hydroxy-propyl)-2-(4-methoxy- phenyl)-4-oxo-azetidin-1-yl)-benzylamide ((2S,3R,4R,5R)-pentahydroxy- hexyl)-amide useful e.g. to treat hyperlipidemia |
| 07/23/2009 | DE102007041654A1 Use of marker sequences for the diagnosis of rheumatoid arthritis, where the marker sequences of a complementary DNA (cDNA) from the specific sequence is determined in a patient |
| 07/23/2009 | DE102005028937B4 Verfahren zur Herstellung von Dronabinol Process for preparing dronabinol |
| 07/23/2009 | CA2787097A1 Low viscosity liquid polymeric delivery system |
| 07/23/2009 | CA2755876A1 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 07/23/2009 | CA2749754A1 Tetrahydropyridoethers for treatment of amd |
| 07/23/2009 | CA2749611A1 Parenteral formulations of dopamine agonists |
| 07/23/2009 | CA2713365A1 Stabilized sustained release composition of bupropion hydrochloride and process for preparing the same |
| 07/23/2009 | CA2712948A1 Phenylacetamide derivative |
| 07/23/2009 | CA2712783A1 Beta-lactamase inhibitors |
| 07/23/2009 | CA2712614A1 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 07/23/2009 | CA2712527A1 Chitosan gel for dermatological use, production method and use of same |
| 07/23/2009 | CA2712443A1 6- and 7-amino isoquinoline compounds and methods for making and using the same |
| 07/23/2009 | CA2712408A1 Platinum complex compound and utilization of the same |
| 07/23/2009 | CA2712404A1 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 07/23/2009 | CA2712367A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments |
| 07/23/2009 | CA2712269A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712267A1 3h-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 07/23/2009 | CA2712266A1 Substituted sulfonamide derivatives |
| 07/23/2009 | CA2712265A1 Substituted sulfonamide derivatives |
| 07/23/2009 | CA2712264A1 Therapeutic beta-lactams |
| 07/23/2009 | CA2712262A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712258A1 Use of isothiocyanate derivatives as anti-myeloma agents |
| 07/23/2009 | CA2712256A1 Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/23/2009 | CA2712245A1 Crystalline (r)-2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide |
| 07/23/2009 | CA2712195A1 Method for treating addiction using quercetin-containing compositions |
| 07/23/2009 | CA2712192A1 Therapeutic compounds |
| 07/23/2009 | CA2712190A1 Oxazolidine and thiazolidine selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 07/23/2009 | CA2712170A1 Stable pharmaceutical composition |
| 07/23/2009 | CA2712141A1 Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers |
| 07/23/2009 | CA2712120A1 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 07/23/2009 | CA2712118A1 Pterin based therapies for inflammatory conditions |
| 07/23/2009 | CA2712017A1 Compounds having crth2 antagonist activity |
| 07/23/2009 | CA2711984A1 Powdered protein compositions and methods of making same |
| 07/23/2009 | CA2711977A1 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/23/2009 | CA2711964A1 Abnormal intraocular pressure treatment |
| 07/23/2009 | CA2711931A1 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological applications thereof |
| 07/23/2009 | CA2711912A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | CA2711737A1 6,7-dialkoxy quinazoline derivatives useful for treatment of cancer related disorders |
| 07/23/2009 | CA2711708A1 Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 07/23/2009 | CA2711690A1 Solid forms of ortataxel |
| 07/23/2009 | CA2711655A1 Condensed aminodihydrothiazine derivative |
| 07/23/2009 | CA2711529A1 Process and intermediates for the preparation of 5-bibphenyl-4-yl-2-methylpentanoic acid derivatives |
| 07/23/2009 | CA2711520A1 Bifeprunox derivatives |
| 07/23/2009 | CA2711384A1 Novel cytostatic 7-deazapurine nucleosides |
| 07/23/2009 | CA2711073A1 Implantable devices for promoting reendothelialization and methods of use thereof |
| 07/23/2009 | CA2710815A1 Combination of metformin and an mtp inhibitor |
| 07/23/2009 | CA2709357A1 Mesalazine tablet |
| 07/23/2009 | CA2708559A1 Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives |
| 07/23/2009 | CA2701492A1 Methods of inhibiting viral infection |